(Q24564977)

1

0 references

B Fotteler

2

0 references

P Heizmann

3

0 references

R Gasser

British Journal of Clinical Pharmacology

4

0 references

language of work or name

English

0 references

publication date

October 1999

0 references

published in

0 references

volume

48

0 references

issue

4

0 references

page(s)

513-20

0 references

cites work

Pharmacokinetic-pharmacodynamic interaction between the COMT inhibitor tolcapone and single-dose levodopa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014389

Effect of liver impairment on the pharmacokinetics of tolcapone and its metabolites

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014389

Multiple-dose clinical pharmacology of the catechol-O-methyl-transferase inhibitor tolcapone in elderly subjects

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014389

Integrated pharmacokinetics and pharmacodynamics of the novel catechol-O-methyltransferase inhibitor tolcapone during first administration to humans

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014389

Catechol-O-methyltransferase activity: a determinant of levodopa response.

30 May 2018

1 reference

Crossref

https://api.crossref.org/works/10.1046%2FJ.1365-2125.1999.00036.X

Optimizing levodopa pharmacokinetics with multiple tolcapone doses in the elderly

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1046%2FJ.1365-2125.1999.00036.X

Identification of major metabolites of the catechol-O-methyltransferase inhibitor entacapone in rats and humans

21 January 2018

1 reference

12 December 2020

Determination of the catechol-O-methyltransferase inhibitor tolcapone and three of its metabolites in animal and human plasma and urine by reversed-phase high-performance liquid chromatography with ultraviolet detection

1 reference

12 December 2020

Tolcapone improves motor function and reduces levodopa requirement in patients with Parkinson's disease experiencing motor fluctuations: a multicenter, double-blind, randomized, placebo-controlled trial. Tolcapone Fluctuator Study Group I

1 reference

12 December 2020

The effect of COMT inhibition by tolcapone on tolerability and pharmacokinetics of different levodopa/benserazide formulations

1 reference

12 December 2020

Effect of tolcapone on plasma levodopa concentrations after coadministration with levodopa/carbidopa to healthy volunteers

1 reference

12 December 2020

10.1046/J.1365-2125.1999.00036.X

Identifiers

DOI

1 reference

release_qzvd2ptrinc7bbqrahc33t2vje

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qzvd2ptrinc7bbqrahc33t2vje

24 November 2022

mapped directly with Wikidata item

1 reference

1 reference

PubMed publication ID

10583021

1 reference